ECMO Treatment

1. Treatment Overview

The Smart T Web Hospital operates Gujarat's most advanced ECMO (Extracorporeal Membrane Oxygenation) program, providing life-saving support for critically ill patients with severe heart and lung failure. Our ECMO center represents the pinnacle of intensive care technology, offering hope when conventional treatments fail.

Since launching our ECMO program in 2012, we have successfully supported over 500 critically ill patients, achieving survival rates that exceed international standards. Our multidisciplinary ECMO team includes cardiac surgeons, intensivists, perfusionists, and specialized nurses trained in the most advanced life support techniques.

                            Why Choose ECMO at The Smart T Web Hospital?
                            24/7 ECMO capability and expertise
Specialized ECMO intensive care unit
Mobile ECMO transport team
Multidisciplinary expert team
Advanced monitoring technology
Superior survival outcomes

                        

2. What is ECMO

2.1 ECMO Definition

External Life Support: Mechanical device that takes over heart/lung function
Oxygenation: Provides oxygen to blood outside the body
Carbon Dioxide Removal: Removes CO2 from blood
Circulation Support: Assists or replaces cardiac pumping
Bridge Therapy: Allows organ recovery or transplantation

2.2 How ECMO Works

Blood Drainage: Blood removed from patient's body
Oxygenator: Artificial lung adds oxygen, removes CO2
Pump: Mechanical pump circulates blood
Heat Exchanger: Maintains appropriate blood temperature
Return: Oxygenated blood returned to patient

2.3 ECMO Circuit Components

Cannulas: Access tubes for blood drainage and return
Tubing: Biocompatible circuit connections
Centrifugal Pump: Modern pump technology
Oxygenator: Hollow fiber membrane lung
Console: Control and monitoring system

3. Types of ECMO

3.1 Venoarterial ECMO (VA-ECMO)

Function: Provides both cardiac and respiratory support
Cannulation: Venous drainage, arterial return
Indications: Cardiogenic shock, cardiac arrest
Benefits: Complete circulatory support
Complications: Higher bleeding risk, limb ischemia

3.2 Venovenous ECMO (VV-ECMO)

Function: Provides respiratory support only
Cannulation: Venous drainage and return
Indications: Severe respiratory failure
Benefits: Lower complication rates
Requirements: Adequate cardiac function

3.3 Venoarterial-venous ECMO (VAV-ECMO)

Configuration: Hybrid VA with additional venous return
Indications: Differential hypoxia
Benefits: Improved upper body oxygenation
Complexity: More complex management
Specialized Use: Selected cases

3.4 Extracorporeal CO2 Removal (ECCO2R)

Function: CO2 removal with minimal flow
Applications: COPD exacerbations
Benefits: Lower anticoagulation needs
Cannulation: Smaller cannulas
Outcomes: Lung-protective ventilation

4. Medical Indications

4.1 Respiratory Indications

ARDS: Acute Respiratory Distress Syndrome
Pneumonia: Severe viral or bacterial pneumonia
Aspiration: Massive aspiration pneumonitis
Trauma: Pulmonary contusion, smoke inhalation
Bridge to Transplant: Lung transplant candidates

4.2 Cardiac Indications

Cardiogenic Shock: Acute heart failure
Post-Cardiotomy: Failed weaning from bypass
Myocarditis: Acute inflammatory heart disease
Myocardial Infarction: Massive heart attack
Bridge to Transplant: Heart transplant candidates

4.3 Pediatric Indications

Congenital Heart Disease: Complex cardiac anomalies
Pediatric ARDS: Severe respiratory failure
Sepsis: Multi-organ failure
Drowning: Severe hypoxic injury
Post-Surgical Support: Cardiac surgery complications

4.4 Emergency Indications

Cardiac Arrest: E-CPR (ECMO CPR)
Massive PE: Pulmonary embolism
Hypothermia: Severe accidental hypothermia
Drug Overdose: Cardiotoxic poisoning
Trauma: Severe thoracic trauma

5. ECMO System Components

5.1 Modern ECMO Console

Control System: Advanced microprocessor control
Safety Features: Multiple alarm systems
Data Recording: Continuous parameter logging
Remote Monitoring: Centralized monitoring capability
Battery Backup: Emergency power systems

5.2 Oxygenator Technology

Hollow Fiber: Polymethylpentene (PMP) membrane
Surface Area: Large gas exchange surface
Durability: Extended use capability
Biocompatibility: Reduced inflammatory response
Integrated Heat Exchanger: Temperature control

5.3 Centrifugal Pump

Magnetic Levitation: Wear-free operation
Flow Control: Precise flow adjustment
Hemolysis: Minimized blood cell damage
Afterload Sensitivity: Automatic flow adjustment
Emergency Stop: Instant cessation capability

5.4 Cannulation Options

Peripheral Cannulation: Femoral, jugular access
Central Cannulation: Direct cardiac access
Bicaval Dual Lumen: Single cannula VV-ECMO
Multistage Cannulas: Optimized drainage
Pediatric Sizes: Neonatal to adolescent

6. Cannulation Procedures

6.1 Peripheral VA-ECMO

Approach: Percutaneous or surgical
Vessels: Femoral artery and vein
Advantages: Rapid initiation, less invasive
Monitoring: Limb perfusion assessment
Complications: Limb ischemia, bleeding

6.2 Central VA-ECMO

Approach: Sternotomy, direct cardiac access
Cannulation: Right atrium, aorta
Advantages: Better flow, chest closure possible
Indications: Post-cardiotomy, pediatric
Considerations: Surgical expertise required

6.3 VV-ECMO Cannulation

Dual Site: Femoral and jugular veins
Single Site: Bicaval dual lumen cannula
Positioning: Echocardiographic guidance
Benefits: Preserved arterial circulation
Recirculation: Minimize circuit recirculation

7. ECMO Management

7.1 Circuit Management

Flow Optimization: Maintain adequate blood flow rates
Oxygenator Function: Monitor gas exchange efficiency
Anticoagulation: Prevent circuit thrombosis
Circuit Surveillance: Regular system inspections
Component Changes: Replace components as needed

7.2 Patient Management

Ventilator Settings: Lung-protective ventilation
Hemodynamics: Cardiovascular support
Fluid Balance: Volume management
Nutrition: Metabolic support
Physical Therapy: Early mobilization

8. Patient Monitoring

8.1 Continuous Monitoring

Hemodynamics: Blood pressure, heart rate, cardiac output
Gas Exchange: Oxygen, carbon dioxide levels
Circuit Parameters: Flow, pressure, temperature
Laboratory Values: Blood gases, coagulation studies
Neurological Status: Consciousness, motor function

8.2 Daily Assessments

Weaning Readiness: Daily evaluation for discontinuation
Complications Screening: Bleeding, thrombosis assessment
Organ Function: Multi-organ system evaluation
Infection Surveillance: Signs of sepsis
Family Communication: Regular updates and support

9. Potential Complications

9.1 Mechanical Complications

Circuit Failure: Pump or oxygenator malfunction
Cannula Problems: Dislodgement or thrombosis
Air Embolism: Air entry into circuit
Hemolysis: Blood cell destruction
Circuit Rupture: Component failure (rare)

9.2 Patient Complications

Bleeding: Anticoagulation-related hemorrhage
Thromboembolism: Blood clot formation
Infection: Bloodstream or surgical site
Limb Ischemia: Reduced blood flow to extremities
Neurological Injury: Stroke or cognitive changes

10. Weaning Process

10.1 Weaning Criteria

Cardiac Recovery: Improved heart function
Pulmonary Recovery: Better lung function
Hemodynamic Stability: Stable blood pressure
Minimal Support: Low flow requirements
Absence of Complications: No major adverse events

10.2 Weaning Protocol

Flow Reduction: Gradual decrease in ECMO flow
Bridge Clamping: Temporary circuit occlusion
Assessment Period: Monitor patient response
Decannulation: Surgical removal of cannulas
Post-ECMO Care: Continued intensive monitoring

11. Treatment Outcomes

65%

Overall Survival Rate

500+

Patients Supported

24/7

Emergency Availability

12

Years Experience

11.1 Survival Rates by Indication

Cardiac Arrest (E-CPR): 40-50% survival to discharge
Cardiogenic Shock: 60-70% survival
Respiratory Failure: 70-80% survival
Post-Cardiotomy: 50-60% survival
Bridge to Transplant: 85-90% successful bridge

12. Contraindications

12.1 Absolute Contraindications

Irreversible Multi-organ Failure: No hope of recovery
Severe Bleeding: Uncontrollable hemorrhage
Advanced Malignancy: Terminal cancer
Severe Neurological Damage: Brain death
Futile Care: No benefit expected

12.2 Relative Contraindications

Advanced Age: >75 years (case by case)
Prolonged Arrest: >60 minutes without CPR
Severe Coagulopathy: High bleeding risk
Immunosuppression: Severe immune compromise
Quality of Life: Severe pre-existing disability

13. ECMO Team

1

ECMO Director

Board-certified intensivist with specialized ECMO training and extensive experience in extracorporeal support.

2

Cardiac Surgeons

Expert surgeons skilled in ECMO cannulation, decannulation, and complex cardiovascular procedures.

3

Perfusionists

Certified clinical perfusionists managing ECMO circuits and providing 24/7 technical support.

4

ECMO Specialists

Dedicated nurses and respiratory therapists trained specifically in ECMO patient care and monitoring.

14. Our ECMO Program

14.1 Program Features

Dedicated ECMO ICU: Specialized intensive care unit
24/7 Availability: Round-the-clock ECMO support
Mobile Team: Emergency transport capabilities
Advanced Technology: Latest ECMO systems
Quality Metrics: Continuous outcome monitoring

14.2 Support Services

Rehabilitation: Physical and occupational therapy
Nutrition: Specialized nutritional support
Social Work: Patient and family support
Chaplaincy: Spiritual care services
Case Management: Discharge planning

15. ECMO Transport

15.1 Mobile ECMO

Emergency Response: Rapid deployment team
Ambulance Transport: Ground transport capability
Helicopter Transport: Air medical transport
Inter-hospital Transfer: Safe patient transport
International Transport: Long-distance capabilities

15.2 Transport Team

ECMO Physician: Critical care specialist
Perfusionist: ECMO technical specialist
Critical Care Nurse: Intensive care nurse
Respiratory Therapist: Ventilation specialist
Transport Coordinator: Logistics management

16. Research and Innovation

16.1 Current Research

Outcome Studies: Long-term survival analysis
Technology Development: Improved ECMO systems
Complications Prevention: Risk reduction strategies
Weaning Protocols: Optimized discontinuation
Quality Improvement: Enhanced patient care

16.2 Future Directions

Artificial Intelligence: AI-assisted ECMO management
Miniaturization: Smaller, more portable systems
Biocompatibility: Improved circuit materials
Remote Monitoring: Telemedicine applications
Preventive ECMO: Earlier intervention strategies

17. Frequently Asked Questions

What is ECMO and when is it used?

ECMO is a life-support system that takes over the function of the heart and lungs when they cannot adequately support the body. It's used in severe heart or lung failure when conventional treatments have failed.

How long can a patient stay on ECMO?

ECMO duration varies by patient condition. Typically, patients are supported for days to weeks. The goal is always to wean off ECMO as soon as the heart or lungs recover sufficiently.

What are the risks of ECMO?

ECMO carries risks including bleeding, infection, stroke, and mechanical complications. However, these risks are balanced against the life-threatening condition being treated.

Can patients be awake on ECMO?

Yes, many ECMO patients can be awake and alert. Some can even participate in physical therapy, eat, and communicate with family while on ECMO support.

What happens after ECMO is removed?

After successful weaning, patients continue intensive care monitoring. Recovery varies, but many patients return to normal or near-normal function with appropriate rehabilitation.

Table of Contents